In this study, we investigate the mechanism by which IDO1 induces angiogenesis in glioma and aim to provide new evidence supporting dual IDO1 and VEGFA blockade as a viable anti-tumor therapeutic strategy. Here, VEGFA is linked to central nervous system cancer.